Table 3.
Asprin (N=25) | No Aspirin (N=67) | P Value | |
---|---|---|---|
ECHO performed (%) | 17 (68.00) | 18 (26.87) | 0.0003 |
Echocardiographic indices | |||
End‐diastolic volume (ml) | 155.93±33.19 | 156.03±39.97 | 0.99 |
Ejection fraction (%) | 52.32±5.91 | 48.97±7.63 | 0.19 |
End‐systolic volume (ml) | 72.40 (55.78, 84.84) | 75.44 (62.96, 94.11) | 0.70 |
Stroke volume (ml) | 80.68±13.38 | 75.70±19.93 | 0.42 |
Global longitudinal strain (3P) (%) | −19.84±2.50 | −17.77±2.60 | 0.03 |
Global longitudinal strain (4CH) (%) | −20.91±3.92 | −19.06±2.58 | 0.12 |
Global longitudinal strain (2CH) (%) | −20.70±2.82 | −19.60±2.48 | 0.24 |
Global longitudinal strain (3CH) (%) | −18.96±2.75 | −16.48±3.02 | 0.02 |
Gestational age | |||
At ECHO (weeks) | 23.43±7.43 | 27.6. ±9.66 | 0.15 |
Aspirin characteristics | |||
Total weeks administered | 16 (5.5, 22.5) | ··· | ··· |
Total weeks administered at ECHO | 6.5 (2.3, 17.5) | ··· | ··· |
Blood pressure | |||
Systolic blood pressure at ECHO (mm Hg) | 133.94±16.62 | 132.89±20.72 | 0.87 |
Diastolic blood pressure at ECHO (mm Hg) | 76.44±14.50 | 80.94±12.20 | 0.33 |
Mean arterial blood pressure at ECHO (mm Hg) | 95.56±13.86 | 98.24±14.23 | 0.58 |
Data are presented as mean±SD, median (quartile 1, quartile 3), or n (%) depending on variable type. These results are assessed between groups with a t test, Wilcoxon Rank Sum, or chi‐square test, respectively. Results for echocardiographic indices and measurements at the time of echo are only reported for patients who ever underwent an echo during pregnancy. ECHO indicates echocardiogram. 3P(Triplane, Average GLS), 4CH(4 chamber), 2CH(2 chamber), 3CH(3 chamber).